<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="oil1000/PMC6414743/results/search/disease/results.xml">
  <result pre="neocnidilide (10.12%). The essential oil showed relatively good anti-MDR M." exact="tuberculosis" post="with MIC = 252 μg/ml. The results of Molecular"/>
  <result pre="carrier protein reductase (InhA) as an important enzyme in M." exact="tuberculosis" post="cell wall biosynthesis. Levisticum officinale Multidrug-resistant- Mycobacterium tuberculosis Essential"/>
  <result pre="in M. tuberculosis cell wall biosynthesis. Levisticum officinale Multidrug-resistant- Mycobacterium" exact="tuberculosis" post="Essential oil Molecular modeling INTRODUCTION Essential oils are beneficial"/>
  <result pre="oils play an important role regarding inhibiting growth of M." exact="tuberculosis" post="and it can be mentioned that essential oils of"/>
  <result pre="as a medicinal plant is used in the treatment of" exact="urinary tract infection" post="and kidney stone ( 6). Its oil is used"/>
  <result pre="antibacterial activity of L. officinale essential oil against MDR M." exact="tuberculosis" post="strain. MATERIALS AND METHODS Plant material. The aerial parts"/>
  <result pre="v4.5 was used. Bacterial strains. An isolate of MDR M." exact="tuberculosis" post="was obtained from the microbial collection of Department of"/>
  <result pre="CDC standard proportional method for multi-drug resistance confirmation of M." exact="tuberculosis" post="( 14– 15). M. tuberculosis H37Rv was used as"/>
  <result pre="multi-drug resistance confirmation of M. tuberculosis ( 14– 15). M." exact="tuberculosis" post="H37Rv was used as standard strain. Determination of MIC."/>
  <result pre="as standard compound. Isoniazid has shown to act on M." exact="tuberculosis" post="by inhibiting a 2-trans-enoyl-acyl carrier protein reductase, called InhA"/>
  <result pre="equal to 11.3%, 55.8% and 17.0% respectively ( 20). M." exact="tuberculosis" post="as an intracellular pathogen causes pandemic tuberculosis (TB) ("/>
  <result pre="( 20). M. tuberculosis as an intracellular pathogen causes pandemic" exact="tuberculosis" post="(TB) ( 21) leading to the death of about"/>
  <result pre="use of novel drugs, especially in the case of multi-drug-resistant" exact="tuberculosis" post="strain. MDR-TB is resistant to conventional drugs such as"/>
  <result pre="carrier protein reductase (InhA) as an important enzyme in M." exact="tuberculosis" post="cell wall biosynthesis. References REFERENCES 1. Taiwo MO Adebayo"/>
  <result pre="Cinnamomumverum), laurel ( Laurusnobilis) and anis ( Pimpinellaanisum) against Mycobacterium" exact="tuberculosis" post=". Adv Biol Chem 2013; 3: 480– 484. 4."/>
  <result pre="docking studies on InhA, MabA and PanK enzymes from Mycobacterium" exact="tuberculosis" post="of ellagic acid derivatives from Ludwigia adscendens and Trewianudiflora"/>
  <result pre="of isoniazid resistance in katG region of MDR isolates from" exact="tuberculosis" post="patients in southern endemic border of Iran . Infect"/>
  <result pre="AA Shojaei H et al. Drug resistance pattern of Mycobacterium" exact="tuberculosis" post="isolates from patients of five provinces of Iran ."/>
  <result pre="Preliminary antimycobacterial study on selected Turkish plants (Lamiaceae) against Mycobacterium" exact="tuberculosis" post="and search for some phenolic constituents . BMC Complement"/>
  <result pre="A Ekinci B Durupinar B. Drug susceptibility testing of Mycobacterium" exact="tuberculosis" post="by the broth microdilution method with 7H9 broth ."/>
  <result pre="expression among drug susceptible and drug resistant strains of Mycobacterium" exact="tuberculosis" post="from Iran . Infect Genet Evol 2015; 36: 23–"/>
  <result pre="X Decker M Heilmann J Wan B et al. Mycobacterium" exact="tuberculosis" post="and cholinesterase inhibitors from Voacangaglobosa . Eur J Med"/>
 </snippets>
</snippetsTree>
